Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Apyx Medical (APYX) over the last 15 years, with Q3 2025 value amounting to $1.8 million.

  • Apyx Medical's Change in Receivables rose 49610.39% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $337000.0, marking a year-over-year decrease of 3300.2%. This contributed to the annual value of $2.0 million for FY2024, which is 4306.1% down from last year.
  • Per Apyx Medical's latest filing, its Change in Receivables stood at $1.8 million for Q3 2025, which was up 49610.39% from -$471000.0 recorded in Q2 2025.
  • In the past 5 years, Apyx Medical's Change in Receivables registered a high of $2.9 million during Q4 2024, and its lowest value of -$3.9 million during Q1 2025.
  • For the 5-year period, Apyx Medical's Change in Receivables averaged around $316578.9, with its median value being $308000.0 (2024).
  • As far as peak fluctuations go, Apyx Medical's Change in Receivables surged by 139484.54% in 2021, and later crashed by 26185.57% in 2025.
  • Apyx Medical's Change in Receivables (Quarter) stood at $1.7 million in 2021, then dropped by 21.81% to $1.4 million in 2022, then rose by 1.99% to $1.4 million in 2023, then surged by 110.85% to $2.9 million in 2024, then crashed by 36.99% to $1.8 million in 2025.
  • Its last three reported values are $1.8 million in Q3 2025, -$471000.0 for Q2 2025, and -$3.9 million during Q1 2025.